Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
1.810
+0.130 (7.74%)
At close: Aug 13, 2025, 4:00 PM
1.730
-0.080 (-4.42%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
QTTB's stock price has decreased by -94.96% in the past year and price targets may not have had time to catch up.
Q32 Bio Analyst Ratings
Total Analysts
8
Consensus Rating
Hold
Price Target
$24.00
Upside
+1,225.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +728.73% | Mar 12, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $22 → $3 | Buy → Hold | Downgrades | $22 → $3 | +65.75% | Feb 11, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $20 → $4 | Buy → Hold | Downgrades | $20 → $4 | +120.99% | Feb 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $64 → $22 | Buy | Maintains | $64 → $22 | +1,115.47% | Dec 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 12, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $80 → $20 | Buy | Maintains | $80 → $20 | +1,004.97% | Dec 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $85 → $20 | Buy | Maintains | $85 → $20 | +1,004.97% | Dec 11, 2024 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $95 → $16 | Buy → Hold | Downgrades | $95 → $16 | +783.98% | Dec 11, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $68 → $9 | Buy → Hold | Downgrades | $68 → $9 | +397.24% | Dec 11, 2024 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $90 → $22 | Strong Buy → Buy | Downgrades | $90 → $22 | +1,115.47% | Dec 11, 2024 |
| BMO Capital | BMO Capital | Buy Initiates $64 | Buy | Initiates | $64 | +3,435.91% | Dec 6, 2024 |
| Raymond James | Raymond James | Strong Buy Initiates $90 | Strong Buy | Initiates | $90 | +4,872.38% | Oct 24, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $95 | Buy | Initiates | $95 | +5,148.62% | Sep 11, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +5,424.86% | Jun 17, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $54 | Buy | Initiates | $54 | +2,883.43% | May 21, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +2,662.43% | Apr 11, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.